CY1113688T1 - IMPROVED IMMUNO DETERMINATION METHODS - Google Patents

IMPROVED IMMUNO DETERMINATION METHODS

Info

Publication number
CY1113688T1
CY1113688T1 CY20131100143T CY131100143T CY1113688T1 CY 1113688 T1 CY1113688 T1 CY 1113688T1 CY 20131100143 T CY20131100143 T CY 20131100143T CY 131100143 T CY131100143 T CY 131100143T CY 1113688 T1 CY1113688 T1 CY 1113688T1
Authority
CY
Cyprus
Prior art keywords
determination methods
antibodies
body fluid
improved immuno
immuno
Prior art date
Application number
CY20131100143T
Other languages
Greek (el)
Inventor
John Forsyth Russell Robertson
Andrea Murray
Caroline Chapman
Tony Barnes
Original Assignee
Oncimmune Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0618055A external-priority patent/GB2441824A/en
Priority claimed from EP07804276A external-priority patent/EP2062053B1/en
Application filed by Oncimmune Ltd filed Critical Oncimmune Ltd
Publication of CY1113688T1 publication Critical patent/CY1113688T1/en

Links

Abstract

Η εφεύρεση αναφέρεται γενικά στο πεδίο των διαγνωστικών ή προγνωστικών προσδιορισμών και ειδικότερα αναφέρεται στους προσδιορισμούς για την ανίχνευση αντισωμάτων σε ένα δείγμα που περιέχει σωματικά υγρά ασθενή, όπου τα αντισώματα αυτά χρησιμοποιούνται ως βιολογικοί δείκτες της κατάστασης της νόσου ή της ευπάθειας στη νόσο. Ο προσδιορισμός βασίζεται στην διασταυρούμενη τιτλοδότηση τόσο των σωματικών υγρών του ασθενή προς έλεγχο για το αντίσωμα όσο και του αντιγόνου που χρησιμοποιείται για την ανίχνευση του αντισώματος με ειδική πρόσδεση.The invention generally relates to the field of diagnostic or prognostic assays, and in particular to the assays for the detection of antibodies in a sample containing body fluid, where these antibodies are used as biological indicators of disease status or disease susceptibility. The assay is based on the cross-titration of both the patient's body fluid to be tested for the antibody and the antigen used to detect the specific binding antibody.

CY20131100143T 2006-09-13 2013-02-15 IMPROVED IMMUNO DETERMINATION METHODS CY1113688T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US84415806A 2006-09-13 2006-09-13
GB0618055A GB2441824A (en) 2006-09-13 2006-09-13 Immunoassay method
EP07804276A EP2062053B1 (en) 2006-09-13 2007-09-12 Improved immunoassay methods

Publications (1)

Publication Number Publication Date
CY1113688T1 true CY1113688T1 (en) 2016-06-22

Family

ID=58448879

Family Applications (2)

Application Number Title Priority Date Filing Date
CY20131100143T CY1113688T1 (en) 2006-09-13 2013-02-15 IMPROVED IMMUNO DETERMINATION METHODS
CY20161100079T CY1117148T1 (en) 2006-09-13 2016-01-28 IMPROVED IMMUNIZATION METHODS

Family Applications After (1)

Application Number Title Priority Date Filing Date
CY20161100079T CY1117148T1 (en) 2006-09-13 2016-01-28 IMPROVED IMMUNIZATION METHODS

Country Status (1)

Country Link
CY (2) CY1113688T1 (en)

Also Published As

Publication number Publication date
CY1117148T1 (en) 2017-04-05

Similar Documents

Publication Publication Date Title
CY1126069T1 (en) DETERMINATION FOR JC VIRUS ANTIBODIES
BRPI0618713B8 (en) modified cardiolipin and its uses
CY1121291T1 (en) SIGNAL STRENGTHENING IMMEDIATES
DE602006007703D1 (en) IMPROVED IMMUNE TEST PROCEDURE
ATE411525T1 (en) DETECTION OF HISTONE MODIFICATION IN CELL-FREE NUCLEOSOMES
NZ601022A (en) Diagnosis and treatment of cancer using anti-ereg antibody
WO2008021290A3 (en) Organ-specific proteins and methods of their use
NO20083820L (en) Detection of cancer at elevated levels of BCL-2
EE05465B1 (en) A method for detecting allergen-associated immunoglobulin in a sample, a method for in vitro diagnosis of a patient's allergies, a microarray chip and a kit
WO2008070865A3 (en) Materials and methods for efficient and accurate detection of analytes
CY1116133T1 (en) THROMBOSPONDIN FRACTIONS AND USE OF THESE IN CLINICAL TESTS FOR CANCER AND CREATING ANTIBODIES AND OTHER CONNECTION FACTORS
ATE469351T1 (en) TURBIDIMETRIC IMMUNOASSAY FOR ASSESSMENT OF HUMAN CYSTATIN C
ATE474857T1 (en) ANTIBODIES TO AN EPITOPE ON AGR2, ASSAY AND HYBRIDOME
CY1113013T1 (en) IMPROVED IMMUNE TEST METHODS
BR0215416A (en) Diagnostic Methods
CY1113688T1 (en) IMPROVED IMMUNO DETERMINATION METHODS
EP2444812A3 (en) Improved immunoassay methods
DK1192469T3 (en) Assay
BRPI0704641B8 (en) rapid test kit and method for detecting and localizing ulcers and other bleeding from the digestive tract in horses using monoclonal and polyclonal antibodies of hemoglobin and equine albumin
ATE515701T1 (en) USE OF A VIRUS EXPRESSING BONDING PART TO MEASURE ANALYTES IN A SAMPLE
CY1115323T1 (en) IMPROVED IMMUNOLOGICAL DETERMINATION METHODS
Kristersson et al. Lateral flow technology-for a quick on-site differentiation of FMDV and other vesicular diseases.
WO2006088739A8 (en) Assays for detecting the tat protein in hiv-1 infection
ATE476652T1 (en) QUANTITATIVE ASSAY FOR RAS P21 IN BODY FLUID